{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:55:16Z","timestamp":1781628916191,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Sastri Family Education Fund Scholarship"},{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","award":["2021-225273"],"award-info":[{"award-number":["2021-225273"]}],"id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000923","name":"Silicon Valley Community Foundation","doi-asserted-by":"publisher","award":["https:\/\/doi.org\/10.37921\/690910twdfoo"],"award-info":[{"award-number":["https:\/\/doi.org\/10.37921\/690910twdfoo"]}],"id":[{"id":"10.13039\/100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-CE17-0011"],"award-info":[{"award-number":["ANR-16-CE17-0011"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-INBS-0006"],"award-info":[{"award-number":["ANR-11-INBS-0006"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Dynamic whole-body PET and total-body PET both supply large datasets that include multiple organs, opening the opportunity to study systems biology via appropriate analysis. Network analysis, commonly used with brain imaging, is applied here with whole-body PET to compare data from different tissues and subjects before and after precipitating a pharmacokinetic drug-drug interaction. This is done with [\n                      <jats:sup>11<\/jats:sup>\n                      C]glyburide PET, a radiotracer whose tissue distribution is mediated by organic anion-transporting polypeptides (OATP) transporter function. OATPs control the uptake of drugs, primarily into the liver. We examine three methods of network analysis to evaluate the effort, efficacy, and potential applications for further research use. This was performed with 22 dynamic [\n                      <jats:sup>11<\/jats:sup>\n                      C]glyburide whole-body PET scans of healthy humans. This includes 13 baseline scans, and 9 after infusion of rifampicin, a potent OATP inhibitor. All methods use Pearson correlation coefficient. The first method generates \u201c\n                      <jats:italic>d-<\/jats:italic>\n                      networks\u201d using dynamic data from one region. The second method generates \u201c\n                      <jats:italic>s-<\/jats:italic>\n                      networks\u201d using static data from multiple regions, but not all regions. The final method generates \u201c\u0394\n                      <jats:italic>PCC<\/jats:italic>\n                      networks\u201d with static data from all regions. The first two methods compare subjects, whereas the third compares regions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The\n                      <jats:italic>d-<\/jats:italic>\n                      network differentiates control and rifampicin subjects within the primary region of interest, the liver, but the differentiation is not complete, and there is still some correlation across subjects (\n                      <jats:italic>r&gt;0.65, p&lt;0.05)<\/jats:italic>\n                      . The\n                      <jats:italic>s-<\/jats:italic>\n                      network completely distinguishes trial groups but requires removing anomalous data from consideration (\n                      <jats:italic>r&gt;0.65, p&lt;0.05)<\/jats:italic>\n                      . Because\n                      <jats:italic>d-<\/jats:italic>\n                      and\n                      <jats:italic>s-<\/jats:italic>\n                      networks require selecting which regions are included, they are informed methods. In contrast, the \u0394\n                      <jats:italic>PCC<\/jats:italic>\n                      networks are uninformed. This method utilises all data and still highlights significant regional variations between the two groups, such as in the liver, while remaining robust to confounding variation (|\n                      <jats:italic>\u0394PCC<\/jats:italic>\n                      |\n                      <jats:italic>&gt;0.18, p&lt;0.05)<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All three methods of network analysis with whole-body PET were successful at identifying key information in the dataset. Each method required different levels of processing and interpretation, making them applicable in different scenarios depending on whether the PET data is dynamic or static, if the kinetics in regions of interest are well understood, and whether the study is focused on comparing between treatment groups or regions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13550-025-01348-x","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:14:25Z","timestamp":1767179665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing three methodologies for network analysis of human [11C]glyburide whole-body PET data: d-networks, s-networks, and \u0394PCC networks"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2627-8185","authenticated-orcid":false,"given":"Abigail F.","family":"Hellman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-4670","authenticated-orcid":false,"given":"Paul S.","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5247-4871","authenticated-orcid":false,"given":"Sol\u00e8ne","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0755-2030","authenticated-orcid":false,"given":"Nicolas","family":"Tournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7505-9144","authenticated-orcid":false,"given":"Adriana A. S.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,31]]},"reference":[{"issue":"2","key":"1348_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00259-018-4153-6","volume":"46","author":"A Rahmim","year":"2019","unstructured":"Rahmim A, Lodge MA, Karakatsanis NA, Panin VY, Zhou Y, McMillan A, et al. Dynamic whole-body PET imaging: principles, potentials and applications. Eur J Nucl Med Mol Imaging. 2019;46(2):501\u201318.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"1348_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2967\/jnumed.122.264555","volume":"64","author":"LKS Sundar","year":"2023","unstructured":"Sundar LKS, Hacker M, Beyer T. Whole-body PET imaging: a catalyst for whole-person research? J Nucl Med. 2023;64(2):197\u20139. https:\/\/doi.org\/10.2967\/jnumed.122.264555.","journal-title":"J Nucl Med"},{"issue":"11","key":"1348_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41573-020-0080-x","volume":"19","author":"T Burt","year":"2020","unstructured":"Burt T, Young G, Lee W, Kusuhara H, Langer O, Rowland M, et al. Phase 0\/microdosing approaches: time for mainstream application in drug development? Nat Rev Drug Discov. 2020;19(11):801\u201318. https:\/\/doi.org\/10.1038\/s41573-020-0080-x.","journal-title":"Nat Rev Drug Discov"},{"key":"1348_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.pharmthera.2018.04.006","volume":"189","author":"N Tournier","year":"2018","unstructured":"Tournier N, Stieger B, Langer O. Imaging techniques to study drug transporter function in vivo. Pharmacol Ther. 2018;189:104\u201322.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1348_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.pharmthera.2018.12.009","volume":"196","author":"SJ McFeely","year":"2019","unstructured":"McFeely SJ, Wu L, Ritchie TK, Unadkat J. Organic anion transporting polypeptide 2B1 \u2013 more than a glass-full of drug interactions. Pharmacol Ther. 2019;196(1):204\u201315.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"1348_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd4461","volume":"14","author":"SK Nigam","year":"2015","unstructured":"Nigam SK. What do drug transporters really do? Nat Rev Drug Discov. 2015;14(1):29\u201344.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"1348_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"International Transporter Consortium, Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KLR, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9(3):215\u201336.","journal-title":"Nat Rev Drug Discov"},{"issue":"17","key":"1348_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0168-3659(01)00480-1","volume":"78","author":"H Kusuhara","year":"2002","unstructured":"Kusuhara H, Sugiyama Y. Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney. J Control Release. 2002;78(17):43\u201354.","journal-title":"J Control Release"},{"key":"1348_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113994","author":"S Marie","year":"2022","unstructured":"Marie S, Breuil L, Chalampalakis Z, Becquemont L, Verstuyft C, Lecoq AL, et al. [11C]glyburide PET imaging for quantitative determination of the importance of organic anion-transporting polypeptide transporter function in the human liver and whole-body. Biomed Pharmacother. 2022. https:\/\/doi.org\/10.1016\/j.biopha.2022.113994.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"1348_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/17425255.2017.1253679","volume":"13","author":"D Kovacsics","year":"2017","unstructured":"Kovacsics D, Patik I, \u00d6zvegy-Laczka C. The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions. Expert Opin Drug Metab Toxicol. 2017;13(4):409\u201324.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"1348_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00418-017-1580-6","volume":"148","author":"M Kim","year":"2017","unstructured":"Kim M, Deacon P, Tirona RG, Kim RB, Pin CL, Meyer zu Schwabedissen HE, et al. Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas. Histochem Cell Biol. 2017;148(4):345\u201357.","journal-title":"Histochem Cell Biol"},{"issue":"5","key":"1348_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","volume":"165","author":"M Roth","year":"2012","unstructured":"Roth M, Obaidat A, Hagenbuch B. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol. 2012;165(5):1260\u201387. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01724.x.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1348_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/clpt.2008.186","volume":"85","author":"H Zheng","year":"2009","unstructured":"Zheng H, Huang Y, Frassetto L, Benet L. Elucidating rifampin\u2019s inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite. Clin Pharmacol Ther. 2009;85(1):78\u201385.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1348_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1053\/jhep.2002.34133","volume":"36","author":"SR Vavricka","year":"2002","unstructured":"Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology. 2002;36(1):164\u201372.","journal-title":"Hepatology"},{"issue":"7","key":"1348_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1124\/dmd.116.074815","volume":"45","author":"R Li","year":"2017","unstructured":"Li R, an Bi Y, Vildhede A, Scialis RJ, Mathialagan S, Yang X, et al. Transporter-Mediated Disposition, Clinical Pharmacokinetics and Cholestatic Potential of Glyburide and Its Primary Active Metabolites. Drug Metab Dispos. 2017;45(7):737\u201347.","journal-title":"Drug Metab Dispos."},{"issue":"4","key":"1348_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.ejps.2012.08.017","volume":"47","author":"A Koenen","year":"2012","unstructured":"Koenen A, K\u00f6ck K, Keiser M, Siegmund W, Kroemer HK, Grube M. Steroid hormones specifically modify the activity of organic anion transporting polypeptides. Eur J Pharm Sci. 2012;47(4):774\u201380.","journal-title":"Eur J Pharm Sci"},{"key":"1348_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1124\/dmd.104.002337","volume":"33","author":"H Satoh","year":"2005","unstructured":"Satoh H, Yamashita F, Tsujimoto M, Murakami H, Koyabu N, Ohtani H, et al. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2005;33:518\u201323.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"1348_CR18","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1016\/j.apsb.2025.03.030","volume":"15","author":"S Marie","year":"2025","unstructured":"Marie S, Lecoq A-L, Breuil L, Caill\u00e9 F, Lebon V, Comtat C, et al. Imaging the impact of sex and age on OATP function in humans: consequences for whole-body pharmacokinetics and liver exposure. Acta Pharm Sin B. 2025;15(5):2736\u201345. https:\/\/doi.org\/10.1016\/j.apsb.2025.03.030.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"1348_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nrn2575","volume":"10","author":"ET Bullmore","year":"2009","unstructured":"Bullmore ET, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10(3):186\u201398.","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"1348_CR20","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000494","volume":"30","author":"I Yakushev","year":"2017","unstructured":"Yakushev I, Drzezga A, Habeck C. Metabolic connectivity: methods and applications. Curr Opin Neurol. 2017;30(6):677.","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"1348_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/ijnp\/pyy100","volume":"22","author":"A Hahn","year":"2019","unstructured":"Hahn A, Lanzenberger R, Kasper S. Making sense of connectivity. Int J Neuropsychopharmacol. 2019;22(3):194\u2013207.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"1348_CR22","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/s41598-019-39005-8","volume":"9","author":"M Veronese","year":"2019","unstructured":"Veronese M, Moro L, Arcolin M, Dipasquale O, Rizzo G, Expert P, et al. Covariance statistics and network analysis of brain PET imaging studies. Sci Rep. 2019;9(1):2496.","journal-title":"Sci Rep"},{"key":"1348_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102349","volume":"27","author":"HK Shim","year":"2020","unstructured":"Shim HK, Lee HJ, Kim SE, Lee BI, Park S, Park KM. Alterations in the metabolic networks of temporal lobe epilepsy patients: a graph theoretical analysis using FDG-PET. NeuroImage: Clinical. 2020;27:102349.","journal-title":"NeuroImage: Clinical"},{"key":"1348_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fnins.2019.00617","volume":"13","author":"A Sala","year":"2019","unstructured":"Sala A, Perani D. Brain molecular connectivity in neurodegenerative diseases: recent advances and new perspectives using positron emission tomography. Front Neurosci. 2019;13:617.","journal-title":"Front Neurosci"},{"issue":"1","key":"1348_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41824-024-00232-6","volume":"9","author":"PM Tuan","year":"2025","unstructured":"Tuan PM, Adel M, Trung NL, Horowitz T, Parlak IB, Guedj E. FDG-PET-based brain network analysis: a brief review of metabolic connectivity. EJNMMI Rep. 2025;9(1):4.","journal-title":"EJNMMI Rep"},{"key":"1348_CR26","doi-asserted-by":"crossref","unstructured":"Sanchez-Catasus CA, M\u00fcller MLTM, De Deyn PP, Dierckx RAJO, Bohnen NI, Melie-Garcia L. Use of Nuclear Medicine Molecular Neuroimaging to Model Brain Molecular Connectivity. In: PET and SPECT in Neurology. Springer, Cham; 2021. p. 181\u2013207.","DOI":"10.1007\/978-3-030-53168-3_8"},{"key":"1348_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.nicl.2017.04.019","volume":"15","author":"CA S\u00e1nchez-Catas\u00fas","year":"2017","unstructured":"S\u00e1nchez-Catas\u00fas CA, Sanabria-Diaz G, Willemsen A, Martinez-Montes E, Samper-Noa J, Aguila-Ruiz A, et al. Subtle alterations in cerebrovascular reactivity in mild cognitive impairment detected by graph theoretical analysis and not by the standard approach. Neuroimage Clin. 2017;15:160.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"1348_CR28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/ncomms1705","volume":"3","author":"A Bashan","year":"2012","unstructured":"Bashan A, Bartsch RP, Kantelhardt JW, Havlin S, Ivanov PC. Network physiology reveals relations between network topology and physiological function. Nat Commun. 2012;3(1):702.","journal-title":"Nat Commun"},{"key":"1348_CR29","doi-asserted-by":"publisher","first-page":"120030","DOI":"10.1016\/j.neuroimage.2023.120030","volume":"271","author":"MB Reed","year":"2023","unstructured":"Reed MB, Ponce de Le\u00f3n M, Vraka C, Rausch I, Godbersen GM, Popper V, et al. Whole-body metabolic connectivity framework with functional PET. Neuroimage. 2023;271:120030.","journal-title":"Neuroimage"},{"issue":"4","key":"1348_CR30","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/mp.17568","volume":"52","author":"J Ruan","year":"2025","unstructured":"Ruan J, Wu Y, Wang H, Huang Z, Liu Z, Yang X, et al. Graph theory analysis of a human body metabolic network: a systematic and organ-specific study. Med Phys. 2025;52(4):2340\u201355. https:\/\/doi.org\/10.1002\/mp.17568.","journal-title":"Med Phys"},{"issue":"8","key":"1348_CR31","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1007\/s00259-022-05832-7","volume":"49","author":"T Sun","year":"2022","unstructured":"Sun T, Wang Z, Wu Y, Gu F, Li X, Bai Y, et al. Identifying the individual metabolic abnormities from a systemic perspective using whole-body PET imaging. Eur J Nucl Med Mol Imaging. 2022;49(8):2994\u20133004.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"1348_CR32","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1007\/s00259-025-07388-8","volume":"52","author":"R Ronghe","year":"2025","unstructured":"Ronghe R, Crespo Gonzalez T, Wimberley C, Suchacki K, Tavares AAS. Innate [18F]fluorodeoxyglucose PET bone networks of lung cancer patients predict survival. Eur J Nucl Med Mol Imaging. 2025;52(13):4952\u201362. https:\/\/doi.org\/10.1007\/s00259-025-07388-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"1348_CR33","doi-asserted-by":"publisher","first-page":"5150","DOI":"10.1007\/s00259-025-07337-5","volume":"52","author":"L Sun","year":"2025","unstructured":"Sun L, Wu Y, Yang J, Liang J, Li P, Yu X, et al. The brain-white adipose tissue axis may play a crucial role in diabetes mellitus: a metabolic network analysis using total-body PET\/CT imaging. Eur J Nucl Med Mol Imaging. 2025;52(13):5150\u201364. https:\/\/doi.org\/10.1007\/s00259-025-07337-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1348_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1597844","author":"AF Hellman","year":"2025","unstructured":"Hellman AF, Clegg PS, Farquharson C, Mill\u00e1n JL, Alcaide-Corral CJ, Suchacki KJ, et al. Distinct bone metabolic networks identified in Phospho1\u2212\/\u2212 mice vs. wild type mice using [18F]FDG total-body PET. Front Med. 2025. https:\/\/doi.org\/10.3389\/fmed.2025.1597844.","journal-title":"Front Med"},{"issue":"19","key":"1348_CR35","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.3390\/cancers16193352","volume":"16","author":"J Yu","year":"2024","unstructured":"Yu J, Spielvogel C, Haberl D, Jiang Z, \u00d6zer \u00d6, Pusitz S, et al. Systemic metabolic and volumetric assessment via whole-body [18F]FDG-PET\/CT: pancreas size predicts cachexia in head and neck squamous cell carcinoma. Cancer. 2024;16(19):3352.","journal-title":"Cancer"},{"key":"1348_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.740615","author":"KJ Suchacki","year":"2021","unstructured":"Suchacki KJ, Alcaide-Corral CJ, Nimale S, Macaskill MG, Stimson RH, Farquharson C, et al. A systems-level analysis of total-body PET data reveals complex skeletal metabolism networks in vivo. Front Med. 2021. https:\/\/doi.org\/10.3389\/fmed.2021.740615.","journal-title":"Front Med"},{"key":"1348_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-022-00884-0","volume":"12","author":"AH Dias","year":"2022","unstructured":"Dias AH, Hansen AK, Munk OL, Gormsen LC. Normal values for 18F-FDG uptake in organs and tissues measured by dynamic whole body multiparametric FDG PET in 126 patients. EJNMMI Res. 2022;12:15.","journal-title":"EJNMMI Res"},{"key":"1348_CR38","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07357-1","author":"MB Reed","year":"2025","unstructured":"Reed MB, Cocchi L, Sander CY, Chen J, Matheson GJ, Fisher P, et al. Connecting the dots: approaching a standardized nomenclature for molecular connectivity in positron emission tomography. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07357-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1348_CR39","doi-asserted-by":"crossref","unstructured":"Tuan PM, Horowitz T, Adel M, Wojak J, Trung NL, Guedj E. Comparative evaluation of graph construction methods for individual brain metabolic network from FDG-PET images: an ADNI study in healthy subjects. Eur J Nucl Med Mol Imaging. 2025 Aug 7.","DOI":"10.21203\/rs.3.rs-6560851\/v1"},{"key":"1348_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010310","author":"TC Freeman","year":"2022","unstructured":"Freeman TC, Horsewell S, Patir A, Harling-Lee J, Regan T, Shih BB, et al. Graphia: a platform for the graph-based visualisation and analysis of high dimensional data. PLoS Comput Biol. 2022. https:\/\/doi.org\/10.1371\/journal.pcbi.1010310.","journal-title":"PLoS Comput Biol"},{"key":"1348_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-88146-1","volume-title":"Stat Anal Netw Data Methods Models","author":"Kolaczyk ED. Ch","year":"2009","unstructured":"Ch Kolaczyk ED. 7 Network Topology Inference. In: Kolaczyk ED, editor. Stat Anal Netw Data Methods Models. New York, NY: Springer; 2009. p. 1\u201348."},{"key":"1348_CR42","unstructured":"Altman DG. Ch. 11.7 Correlation - Mathematics and Worked Examples. In: Altman DG, editor. Pract Stat Med Res. Milton, UK: CRC Press LLC; 1990. p. 293\u20134."},{"issue":"3","key":"1348_CR43","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/00031305.1992.10475879","volume":"46","author":"NS Altman","year":"1992","unstructured":"Altman NS. An introduction to kernel and nearest-neighbor nonparametric regression. Am Stat. 1992;46(3):175\u201385. https:\/\/doi.org\/10.1080\/00031305.1992.10475879.","journal-title":"Am Stat"},{"key":"1348_CR44","unstructured":"Hall JE, Hall ME. Ch. 65. In: Hall JE, Hall ME, editors. Guyton and Hall Textbook of Medical Physiology. 14th ed. Elsevier; 2021."},{"issue":"22","key":"1348_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw772","volume":"44","author":"X Liu","year":"2016","unstructured":"Liu X, Wang Y, Ji H, Aihara K, Chen L. Personalized characterization of diseases using sample-specific networks. Nucleic Acids Res. 2016;44(22):e164.","journal-title":"Nucleic Acids Res"},{"key":"1348_CR46","doi-asserted-by":"publisher","DOI":"10.1201\/9780429258589","volume-title":"Practical statistics for medical research","author":"DG Altman","year":"1990","unstructured":"Altman DG. Practical statistics for medical research. Milton, UK: CRC Press LLC; 1990."}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01348-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01348-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:00:16Z","timestamp":1781625616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13550-025-01348-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1348"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01348-x","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,31]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee (CPP IDF 5: 17041). Signed informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Fig.\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}